BIOSIGHT
BioSight is a biopharmaceutical private company founded in 2000 and re launched in mid 2009, revolutionizing the research and development of innovative cancer targeted pro-drugs. BioSight has developed technology S2DOT TM and a pipeline of targeted pro-drugs, that can target and release chemotherapy drugs inside cancer cells, while significantly minimizing the systemic toxicity associated with conventional chemotherapy ​​treatments.​​​
BIOSIGHT
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Carmiel, HaZafon, Israel
Country:
Israel
Website Url:
http://www.biosight-pharma.com
Total Employee:
1+
Status:
Active
Contact:
972 4 958 1519
Email Addresses:
[email protected]
Total Funding:
59 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
KBP Biosciences
A multinational clinical stage biotechnology company.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Employees Featured
Founder
Investors List
Migdal Insurance and Financial Holdings
Migdal Insurance and Financial Holdings investment in Series C - BioSight
Israel Biotech Fund
Israel Biotech Fund investment in Series C - BioSight
Arkin Bio Ventures
Arkin Bio Ventures investment in Series C - BioSight
Primera Capital
Primera Capital investment in Series C - BioSight
Phoenix Insurance Company
Phoenix Insurance Company investment in Series C - BioSight
Biotel
Biotel investment in Series C - BioSight
Arkin Bio Ventures
Arkin Bio Ventures investment in Series C - BioSight
Israel Biotech Fund
Israel Biotech Fund investment in Series C - BioSight
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series C - BioSight
Arkin Holdings
Arkin Holdings investment in Venture Round - BioSight
Official Site Inspections
http://www.biosight-pharma.com Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "BioSight"
BioSight - Innovative Cancer Therapeutics
BioSight's BST-236 is developed for acute myeloid leukemia treatment. BioSight is a …See details»
BioSight - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +972.3.6568669; BioSight is a biopharmaceutical private company founded in 2000 and re …See details»
BioSight Company Profile 2024: Valuation, Investors ... - PitchBook
BioSight General Information Description. Developer of novel peptide-based drugs designed to …See details»
Ayala Pharmaceuticals and Biosight Enter into Definitive
Jul 27, 2023 Biosight’s lead product, aspacytarabine (BST-236), is an innovative proprietary …See details»
BioSight - Products, Competitors, Financials, Employees, …
BioSight. Frequently Asked Questions (FAQ) When was BioSight founded? BioSight was …See details»
Biosight - Overview, News & Similar companies | ZoomInfo.com
Aug 1, 2022 Biosight contact info: Phone number: +972 49581519 Website: www.biosight …See details»
BioSight Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioSight Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical …See details»
Biosight Ltd. - LinkedIn
Biosight’s lead product, BST-236 (aspacytarabine), is an innovative proprietary anti-metabolite …See details»
BioSight | VentureRadar
BioSight is a private pharmaceutical development company founded in 2000. We focus on …See details»
BioSight’s Competitors, Revenue, Number of Employees, Funding …
BioSight’s Profile, Revenue and Employees. BioSight is a pharmaceutical company that …See details»
Biosight Company Profile - Office Locations, Competitors ... - Craft
Biosight has 5 employees at their 1 location and $32 m in total funding,. See insights on …See details»
BioSight - LinkedIn
BioSight | 186 followers on LinkedIn. BioSight is Biopharmaceutical Company focused on the …See details»
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Oct 19, 2023 REHOVOT, Israel & MONMOUTH JUNCTION, N.J., Oct. 19, 2023 (GLOBE …See details»
Advaxis and Biosight Announce Entry into Definitive Merger …
Jul 6, 2021 – Combined Company Will Operate as Biosight Therapeutics to Advance Pipeline …See details»
BioSight - Israeli Startup | Startup Nation Finder
Dec 2, 2020 Biosight is a phase-2 clinical-stage biotechnology company developing …See details»
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger …
Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage …See details»
Information and News about biosight - preipopharma.com
Biosight is a private Phase 2 clinical stage biotech company developing innovative therapeutics …See details»
Advaxis and Biosight Announce Entry into Definitive Merger
Jul 6, 2021 White & Case and Horn & Co. are serving as legal counsel to Biosight. …See details»
BioSight - The Trendlines Group
Trendlines’ shares in BioSight were acquired by Arkin Bio Ventures Ltd. in June 2017. BioSight …See details»